In vivo targeting of activated leukocytes by a β2-integrin binding peptide.
Ranta TM, Suojanen J, Peñate-Medina O, Will O, Tower RJ, Glüer C, Kairemo K, Gahmberg CG, Koivunen E, Sorsa T, Saris PE, Reunanen J.
Ranta TM, et al.
Mol Diagn Ther. 2014 Feb;18(1):39-44. doi: 10.1007/s40291-013-0052-5.
Mol Diagn Ther. 2014.
PMID: 23982749